ESR1 and neoplasm: In an elegant study of estrogen action in cancers that do not express estrogen receptors (ovarian, lung, and mammary ER-negative tumor models), Conejo-Garcia and his colleagues demonstrated that 17β-estradiol drove tumor growth by ERα-mediated expansion, mobilization, and activation of MDSCs (mostly gMDSCs).